tert-Butyl 6-(benzyloxy)-4-fluoro-1H-indazole-1-carboxylate, 95.0%, 250mg

Xphos, mínimo 97 %, 10 g, envase de vidrio

(2-Bromo-4-methylthiazol-5-yl)methanol, 97%, 100mg

3-Hydroxy-2-pyrrolidinone, 95.0%, 25g

(R)-2-(2,5-Difluorophenyl)pyrrolidine hydrochloride, 95.0%, 100mg

(2-Isopropoxy-5-(trifluoromethoxy)phenyl)boronic acid, 97%, 5g

5-(3-Aminophenyl)oxazole, 95.0%, 5g

(S)-2-GUANIDINOSUCCINIC ACID, 97%, 100mg

(R)-2-((tert-Butoxycarbonyl)amino)-2-(thiophen-3-yl)acetic acid, 95.0%, 1g

MLI-2, 95%, 1mg

2-METHYL-2-NITRO-1,3-PROPANEDIOL, 95.0%, 5g

1-(3-Bromophenyl)-2-hydroxyethan-1-one, 95%, 1g

4,4,5,5-Tetramethyl-2-(3,3,5,5-tetramethyl-1-cyclohexen-1-yl)-1,3,2-dioxaborolane, 95.0%, 250mg